Task: Answer the multiple choice question.
Query: Which drug has a 11.410\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
(a) O=C(Cc1ccccc1)NNC(=O)c1cnccn1
(b) CCOc1cc([C@@H]2C[C@H]3CN(c4ccccc4)C(=O)[C@]34CCCN24)ccc1OC
(c) Nc1cc(N)nc(SCC(=O)Nc2ccc(Br)cc2Cl)n1
Answer: c. Nc1cc(N)nc(SCC(=O)Nc2ccc(Br)cc2Cl)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Nc1cc(N)nc(SCC(=O)Nc2ccc(Br)cc2Cl)n1
Nc1cc(N)nc(SCC(=O)Nc2ccc(Br)cc2Cl)n1
N-(4-bromo-2-chlorophenyl)-2-(4,6-diaminopyrimidin-2-yl)sulfanylacetamide